With the aging population, osteoporosis and osteoporotic fractures are becoming more prevalent. Adequate screw fixation in this type of bone is difficult. Screws are often cemented in bone to help obtain purchase. However, current cementing techniques do not ensure implant stability. Here we present
Properties of an injectable low modulus PMMA bone cement for osteoporotic bone
β Scribed by Andreas Boger; Marc Bohner; Paul Heini; Sophie Verrier; Erich Schneider
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 222 KB
- Volume
- 86B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The use of polymethylmethacrylate (PMMA) cement to reinforce fragile or broken vertebral bodies (vertebroplasty) leads to extensive bone stiffening. Fractures in the adjacent vertebrae may be the consequence of this procedure. PMMA with a reduced Young's modulus may be more suitable. The goal of this study was to produce and characterize stiffness adapted PMMA bone cements. Porous PMMA bone cements were produced by combining PMMA with various volume fractions of an aqueous sodium hyaluronate solution. Porosity, Young's modulus, yield strength, polymerization temperature, setting time, viscosity, injectability, and monomer release of those porous cements were investigated. Samples presented pores with diameters in the range of 25β260 ΞΌm and porosity up to 56%. Young's modulus and yield strength decreased from 930 to 50 MPa and from 39 to 1.3 MPa between 0 and 56% porosity, respectively. The polymerization temperature decreased from 68Β°C (0%, regular cement) to 41Β°C for cement having 30% aqueous fraction. Setting time decreased from 1020 s (0%, regular cement) to 720 s for the 30% composition. Viscosity of the 30% composition (145 Pa s) was higher than the ones received from regular cement and the 45% composition (100β125 Pa s). The monomer release was in the range of 4β10 mg/mL for all porosities; showing no higher release for the porous materials. The generation of pores using an aqueous gel seems to be a promising method to make the PMMA cement more compliant and lower its mechanical properties to values close to those of cancellous bone. Β© 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008
π SIMILAR VOLUMES
## Abstract Poly (methyl methacrylate) (PMMA) bone cement is widely used in vertebral body augmentation procedures such as vertebroplasty and balloon kyphoplasty. Filling high modulus PMMA increases the modulus of filled verterbra, increasing the risk of fracture in the adjacent vertebra. On the ot
## Abstract Calcium phosphate cement (CPC) that can be injected to form a scaffold in situ has promise for the repair of bone defects. However, its lowβstrength limits the CPC to nonβstressβbearing repairs. Fibrin glue (FG) with good sticking property and biocompatibility is possible used to reinfo
With the objectives of reducing toxicity and improving the mechanical properties of the prior Sulfixm-6 cement, a new low-viscosity bone cement with a new catalyst (Sulfix@-60), and a gentamycin containing cement (Allofix-Gm) were developed. Although static strength could be improved in comparison w
## Abstract Injectable bone cements (IBCs) are used for a variety of orthopaedic applications, examples being poly (methyl methacrylate) (PMMA) bone cements used for anchoring total joint replacements (TJRs) (high loadβbearing application), PMMA bone cements used in the vertebral body augmentation
## Abstract The interventional radiological techniques of vertebroplasty (VP) and balloon kyphoplasty (BKP) are widely used in cases where the pain secondary to compression fractures of vertebral bodies is severe, persistent, and refractory to conservative treatments. In the majority of VP and BKP